AKT1 and melanoma: To determine whether PI3kinase-AKT signalling was required for induction of PD-L1 expression the melanoma cells were treated with inhibitors of PI3K (LY294002 and BKM120) and with a dual inhibitor of PI3K and mTOR (BEZ235).